Natural Biologics and Aleris International debuted Provillus to the U.S. Poultry and Swine industries at an exclusive launch event held during the International Production and Processing Expo (IPPE) in Atlanta, GA.
Provillus is a unique combination of yeast postbiotics and fermentation extracts, Microbiota Activating Compound technology, distinctive probiotics, and other natural bioactive compounds. New research, presented during the event, demonstrated Provillus’ efficacy against Blackhead disease and coccidiosis in turkey poults and broilers. The recent research was completed at the University of Arkansas and Mississippi State University.
“We are very excited to be the exclusive U.S. distributor of Provillus and partnering with Aleris International to bring this exciting new technology to domestic poultry and swine producers,” says Dr. Charlie Elrod, co-founder and CEO of Natural Biologics. “With the Aleris Microbiota Activating Compound technology and artificial intelligence, we can identify the impact Provillus is having on the beneficial microbes in the gut. This leads to more effective and efficient products for the animals.”
To learn more about Natural Biologics and the new Provillus research, visit NaturalBiologics.com/product/provillus/.
About Natural Biologics
Natural Biologics was founded in 2015 to provide innovative, natural solutions for agriculture producers to manage risk and improve the health and productivity of animals and crops across the world. Focusing on our core values of integrity, relationships and innovation, Natural Biologics builds lasting partnerships with customers, suppliers and employees. With Natural Biologics as part of the team, our customers will be better able to provide a growing global population with safe, sustainable and healthy food. Learn more about Natural Biologics’ full line of animal health solutions by visiting www.NaturalBiologics.com. For additional information, contact Dr. Charlie Elrod, President & CEO,
